Literature DB >> 16810202

Histone deacetylase inhibitors have antitumor activity in two NOD/SCID mouse models of B-cell precursor childhood acute lymphoblastic leukemia.

H Graf Einsiedel, L Kawan, C Eckert, O Witt, I Fichtner, G Henze, K Seeger.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16810202     DOI： 10.1038/sj.leu.2404282

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  7 in total

Review 1.  The role of HDACs inhibitors in childhood and adolescence acute leukemias.

Authors:  Riccardo Masetti; Salvatore Serravalle; Carlotta Biagi; Andrea Pession
Journal:  J Biomed Biotechnol       Date:  2011-01-13

2.  YY1 regulated transcription-based stratification of gastric tumors and identification of potential therapeutic candidates.

Authors:  Divya Bhaskar Rao; Ponmathi Panneerpandian; Karthik Balakrishnan; Kumaresan Ganesan
Journal:  J Cell Commun Signal       Date:  2021-02-23       Impact factor: 5.782

3.  A phase I trial of vorinostat and bortezomib in children with refractory or recurrent solid tumors: a Children's Oncology Group phase I consortium study (ADVL0916).

Authors:  Jodi A Muscal; Patrick A Thompson; Terzah M Horton; Ashish M Ingle; Charlotte H Ahern; Renee M McGovern; Joel M Reid; Matthew M Ames; Igor Espinoza-Delgado; Brenda J Weigel; Susan M Blaney
Journal:  Pediatr Blood Cancer       Date:  2012-08-09       Impact factor: 3.167

Review 4.  Pediatric relapsed or refractory leukemia: new pharmacotherapeutic developments and future directions.

Authors:  Keith J August; Aru Narendran; Kathleen A Neville
Journal:  Drugs       Date:  2013-04       Impact factor: 9.546

5.  The DAC system and associations with acute leukemias and myelodysplastic syndromes.

Authors:  Gesine Bug; Oliver G Ottmann
Journal:  Invest New Drugs       Date:  2010-12-14       Impact factor: 3.850

6.  Influence of Histone Deacetylase Inhibitors and DNA-Methyltransferase Inhibitors on the NK Cell-Mediated Lysis of Pediatric B-Lineage Leukemia.

Authors:  Matthias Manuel Pfeiffer; Helen Burow; Sabine Schleicher; Rupert Handgretinger; Peter Lang
Journal:  Front Oncol       Date:  2013-04-29       Impact factor: 6.244

Review 7.  Histone acetylation: novel target for the treatment of acute lymphoblastic leukemia.

Authors:  Cheng Zhang; Jiang F Zhong; Andres Stucky; Xue-Lian Chen; Michael F Press; Xi Zhang
Journal:  Clin Epigenetics       Date:  2015-11-04       Impact factor: 6.551
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.